Mario Alberto Battaglia

Title: Mario Alberto Battaglia: Innovator in Neurodegenerative Disease Treatment

Introduction

Mario Alberto Battaglia is a notable inventor based in Genoa, Italy. He has made significant contributions to the field of neurodegenerative diseases through his innovative research and patent work. His expertise lies in developing chemical compounds that target specific receptors, which can lead to advancements in medical treatments.

Latest Patents

Mario Alberto Battaglia holds a patent for GPR17 receptor modulators. This patent involves chemical compounds that act on GPR17 receptors and are useful in the treatment or amelioration of chronic and/or acute neurodegenerative diseases. These diseases include multiple sclerosis, inflammatory diseases, pathologies involving the immune system, cardiovascular diseases, and renal diseases. His work in this area is crucial for developing new therapeutic options for patients suffering from these conditions.

Career Highlights

Throughout his career, Battaglia has been associated with prestigious institutions such as Università Degli Studi Di Milano and Fondazione Italiana Sclerosi Multipla—FISM Onlus. His work in these organizations has allowed him to collaborate with other experts in the field and contribute to significant advancements in medical research.

Collaborations

Some of his notable coworkers include Maria Pia Abbracchio and Ivano Eberini. Their collaborative efforts have further enhanced the impact of Battaglia's research and innovations in the medical community.

Conclusion

Mario Alberto Battaglia is a prominent figure in the field of neurodegenerative disease research, with a focus on developing effective treatments through his patented innovations. His contributions continue to pave the way for advancements in medical science.